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A 67 year old man presents with a growing infrarenal abdominal aortic aneurysm. He has been a heavy smoker,
has a history of myocardial infarction 2 years ago, and suffers from moderate renal impairment. The pre-
operative CT angiogram reveals a favorable anatomy for EVAR but shows a relatively large and patent infe-
rior mesenteric artery. Should I coil this artery during or before EVAR?Type II endoleak is a common condition occurring after endovascular repair of abdominal aortic aneurysms
(EVAR), and may result in aneurysm sac growth and/or rupture in a small number of patients. A prophylactic
strategy of inferior mesenteric artery (IMA) embolization before EVAR has been advocated, however, the beneﬁts
of this strategy are controversial. A clinical vignette allows the authors to summarize the available data about this
issue and discuss the possible beneﬁts and risks of prophylactic IMA embolization before EVAR. The authors
performed a meta-analysis of available data which showed that the pooled rate of type II endoleak after IMA
embolization was 19.9% (95% CI 3.4e34.7%, I2 93%) whereas it was 41.4% (95% CI 30.4e52.3%, I2 76%) in
patients without IMA embolization (5 studies including 596 patients: p < .0001, OR 0.369, 95% CI 0.22e0.61, I2
27%). Since treatment for type II endoleaks is needed in less than 20% of cases and this complication can be
treated successfully in 60e70% of cases resulting in an aneurysm rupture risk of 0.9%, these data indicate that
embolization of patent IMA may be of no beneﬁt in patients undergoing EVAR.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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It is the result of retrograde blood ﬂow into the aneurysm
sac from patent aortic vessels such as the inferior mesen-
teric artery (IMA), the lumbar arteries, and the median
sacral artery through collateral circulation.1e3 A patent IMA
is considered a major source of type II endoleak.1,4 The
number of additional patent aortic branches is also associ-
ated with an increased risk of such endoleaks.1,5
Type II endoleak is considered the least severe type of
endoleak occurring after EVAR. Still, in a small number of
patients, type II endoleak may result in aneurysm sacrresponding author.
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//dx.doi.org/10.1016/j.ejvs.2015.06.116growth and/or rupture. Since the treatment of this endo-
leak is sometimes technically difﬁcult with suboptimal re-
sults,6,7 a prophylactic strategy of IMA embolization before
EVAR has been advocated.
The incidence of type II endoleak detected at computed
tomography after EVAR ranges from 3% to 25%,8e10 and it
is likely to be higher when magnetic resonance imaging is
used.11 Between 50% and 80%12,13 of such leaks resolve
spontaneously within the ﬁrst 6 months of the operation
and no treatment is indicated. However, a minority of type
II endoleaks persist or others may appear later on, and this
may cause concern regarding their impact on the fate of the
aneurysm sac.4
PROGNOSTIC IMPACT OF TYPE II ENDOLEAK
Studies regarding the signiﬁcance of type II endoleak have
shown contradictory results. Some studies have shown that
type II endoleaks are associated with a benign course.14,15
However, most studies are in agreement that type II
672 F. Biancari et al.endoleak may result in persistently elevated intra-sac
pressure and failure of aneurysm sac shrinkage.15 A few
studies concluded that persistent type II endoleak is asso-
ciated with adverse outcomes such as aneurysm sac growth
and rupture and therefore requires re-intervention.4,12
In a recent meta-analysis of 32 studies including 21,744
patients, type II endoleak after EVAR was detected in 10.2%
of patients.8 About 35% of these endoleaks resolved
spontaneously. Three hundred and ninety three (26%) in-
terventions for type II endoleak were performed with a
success rate of 71.5%. Fourteen patients (0.9%) with iso-
lated type II endoleak had ruptured abdominal aortic
aneurysm, six of them without any sign of aneurysm sac
growth. Another meta-analysis16 was not able to deﬁne a
threshold for treatment of type II endoleak as the aggres-
sive treatment of type II endoleak not associated with sac
expansion did not provide better results than a more con-
servative strategy (intervention only in cases of type II
endoleak with sac expansion > 5 mm or persistent type II
endoleak for > 12 months). No aneurysm rupture occurred
in this pooled series. However, type II endoleak associated
with an aneurysm sac growth  10 mm is considered an
indication for endovascular, laparoscopic or open repair.17
IMPACT OF INFERIOR MESENTERIC EMBOLIZATION PRIOR
TO EVAR IN PREVENTING TYPE II ENDOLEAK
Although EVAR has been performed for almost three de-
cades, there are only ﬁve studies adequately comparing the
outcome of IMA embolization with a conservative strat-
egy.18e22 The results of these series have been pooled here
using the random effects method. Statistical analysis was
performed using Open meta-analysis statistical software
(http://www.cebm.brown.edu/open_meta). These ﬁve
studies reported on 246 patients who underwent IMA
embolization with or without embolization of patent lumbar
arteries and their outcome was compared with that of 350
patients with patent IMA and who did not undergo pro-
phylactic embolization of the aortic branches. Two studies
performed IMA embolization with Amplazer19,20 and the
others by coiling.18,21,22 In a few cases, embolization of
lumbar arteries was performed as well. The embolization
procedure had a success rate of 98.4% (95% CI 96.3e100%).
The rate of type II endoleak after IMA embolization was
19.9% (95% CI 3.4e34.7%, I2 93%) whereas it was 41.4%
(95% CI 30.4e52.3%, I2 76%) in patients without IMAFigure 1. Forest plot showing the impact of pre-operative inferior mese
the development of type II endoleak in patients with patent IMA undembolization (p < .0001, OR 0.369, 95% CI 0.222e0.613, I2
27%) (Fig. 1). Lumbar arteries were responsible for type II
endoleak in a few patients.18 Four studies18e20,22 reported
on the number of patients who required re-intervention for
type II endoleak and this was signiﬁcantly lower after IMA
embolization (1.2% vs. 13.4%, p < .0001, OR 0.091, 95% CI
0.027e0.301, I2 0%). However, the threshold for interven-
tion varied signiﬁcantly between studies. Two studies re-
ported on aneurysm related mortality, which was nil in
both.21,22 One patient developed mesenteric ischemia after
IMA embolization and died.22 No homogeneous data were
reported on the rate of growth of the aneurysm sac in these
studies. In one study,21 the overall linearized aneurysm
shrinkage rate was 1.4  3.8 mm per year in the IMA
embolization group and 1.7  2.4 mm per year in the
control group (p < .72).
DIAMETER OF THE INFERIOR MESENTERIC ARTERY AND
OCCURRENCE OF TYPE II ENDOLEAK
The impact of the size of IMA on the occurrence of type II
endoleak is a matter of intense debate. Fukuda et al.10
observed that the diameter of the proximal IMA was
larger than 2.5 mm in 24% (26/106) of patients without
type II endoleak, in 50% of those with transient endoleak
(5/10), and 100% (5/5) in patients with persistent endoleak.
In multivariate analysis, the absence of stenosis of the IMA
at its oriﬁce was more likely to be a signiﬁcant factor of
persistent type II endoleak (p¼ .0003), and thrombus at the
oriﬁce of the IMA was a negative predictor of persistent
type II endoleak (p ¼ 0.043).10 Otsu and colleagues5
conﬁrmed these ﬁndings and showed that an IMA
diameter > 2.5 mm along with each additional patent
lumbar artery  1.9 mm were predictors of permanent type
II endoleak. Similarly, Müller-Wille and colleagues23
observed that patients without complex IMA and lumbar
artery type II endoleak in whom the largest feeding and/or
draining artery was larger than 3.8 mm, and patients with a
complex IMA type II endoleak in whom the largest feeding
and/or draining artery was larger than 2.2 mm were at high
risk for aneurysm sac enlargement.
Another study showed the signiﬁcant association be-
tween the diameter of the IMA and the occurrence of type
II endoleak.24 However, multivariate analysis showed that
the number and diameter of patent lumbar arteries were
the only predictors of permanent type II endoleak requiringnteric artery (IMA) embolization versus conservative treatment on
ergoing endovascular repair of abdominal aortic aneurysm.
Inferior Mesenteric Artery Embolization 673treatment.24 Other studies conﬁrmed the lack of association
between the diameter of the IMA and the development of
type II endoleak1,4 and rather suggested that the number of
patent lumbar arteries was a risk factor for such an
endoleak.1POTENTIAL ADVERSE EVENTS ASSOCIATED WITH INFERIOR
MESENTERIC ARTERY EMBOLIZATION
A few serious complications have been reported after
embolization of the IMA. Post-operative death secondary to
colonic ischemia has been reported as a result of catheter
directed embolization of the IMA prior to EVAR6,22,25 and
for treatment of type II endoleak.26 Overall, the incidence of
mesenteric ischemia in extremely low.22 Aortitis has been
observed after percutaneous endovascular coil emboliza-
tion prior to EVAR.27 Since IMA embolization is associated
with a signiﬁcantly increased use of contrast agent,21 the
potential risk of acute kidney injury should be considered in
the decision making process in patients with decreased
renal function.Cost related issues with inferior mesenteric artery
embolization
The cost of pre-operative embolization with an Amplatzer
device has been estimated to be about 300 euros and of
coils ranging from 360 to 600 euros.19 However, considering
the current clinical practice in which type II endoleaks are
actively treated only in case of aneurysm growth, it is
evident that routine pre-operative IMA embolization is not
cost-effective.21CLINICAL DECISION IN THIS PATIENT
The present patient is rather young, but has a history of
myocardial infarction and of moderate renal failure, which
may increase his operative and late mortality risk.24e30 He
has been a heavy smoker and this may further decrease his
life expectancy.31 If it is assumed that his moderate renal
insufﬁciency is equivalent to a creatinine serum level >
150 mmol/L, the Glasgow Aneurysm Score would be 88.
According to the Eurostar registry data, the 30 day mortality
risk of this patient would be about 5% and his 6 year sur-
vival would be about 60%.32 Such a high operative risk
suggests that he most certainly would beneﬁt from a
straightforward EVAR without IMA embolization. This
strategy would also prevent any further risk of acute kidney
injury possibly associated with the use of a larger amount of
contrast.
There are a few data showing that smoking habit is
associated with a lower risk of type II endoleak after
EVAR.33e35 Such a lower risk of endoleak can be related to
the decreased perfusion of the IMA and lumbar arteries in
previous and current smokers compared with non-
smokers.34 Indeed, universal atherosclerosis in heavy
smokers may affect the visceral arteries and impair the
retrograde collateral circulation to the aneurysm sac. Since
this patient has been a heavy smoker, it may be expectedthat his risk of developing a type II endoleak secondary to a
patent IMA is signiﬁcantly reduced.
Pooled analysis of available data indicates that IMA
embolization is associated with signiﬁcantly lower risk of
type II endoleak, but the pooled rate of this event is still
about 20% among these patients and other aortic branches
may be responsible for endoleak. Therefore, type II endo-
leak cannot be prevented in all patients solely by IMA
embolization. Indeed, large lumbar arteries are associated
with the occurrence of type II endoleak,36 and their
contribution may be more signiﬁcant than the IMA.2,24
Therefore, accurate imaging evaluation of the lumbar ar-
teries is needed to better estimate the real value of IMA
embolization when a large number of lumbar arteries are
patent.
Since treatment for type II endoleaks is needed in less
than 20% of cases and this complication can be treated
successfully in 60e70% of cases,21 resulting in an aneurysm
rupture risk of 0.9%,8 it is believed that embolization of
patent IMA before EVAR is not indicated in this high risk
patient.
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